Gene Therapy List of articles

2026.11.17

White,medical,pills,and,tablets,spilling,out,of,a,drug

Japan Moves Toward Approval of Gene Therapy Libmeldy for Metachromatic Leukodystrophy

Regulatory Committee Supports Approval of Libmeldy in Japan Japan is moving toward approval of Libmeldy, a gen […]

COMPANY

Company Name: Eliquent Japan, Inc.
Location: Shinjuku i-Land Tower 41F, 6-5-1 Nishi Shinjuku, Shinjuku-ku 163-1341 Tokyo, Japan
Representative Director, CEO: Shunsuke Iwano
Business Scope: Regulatory Consulting
Phone:+81-3-6304-5570